[1] Yamakawa T, Suzuki S. The chemistry of the lipids of posthemolytic residue or stroma of erythrocytes I concerning the ether-insoluble lipids of lyophilized horse Bblood stroma [J]. J Biochem, 1951, 38 (2): 199-212.
[2] Giussani P, Tringali C, Riboni L, et al. Sphingolipids: key regulators of apoptosis and pivotal players in cancer drug resistance [J]. Int J Mol Sci, 2014, 15 (3): 4356-4392.
[3] Tringali C, Silvestri I, Testa F, et al. Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles [J]. BMC cancer, 2014, 14 (1): 560.
[4] Duclos JR. The total synthesis of ganglioside GM3 [J]. Carbohydr Res, 2000, 328 (4): 489-507.
[5] Imamura A, Yoshikawa T, Komori T, et al. Design and synthesis of versatile ganglioside probes for carbohydrate microarrays [J]. Glycoconj J, 2008, 25 (3): 269-278.
[6] Zheng M, Ye XS. Synthesis of N-modified ganglioside GM3 derivatives [J]. Tetrahedron Lett, 2012, 68 (5): 1475-1482.
[7] 李相鹏, 王 鹏, 李英霞. 全乙酰 GM3 三糖对甲氧基苯酚苷的合成[J].合成化学, 2010, 18 (5): 538-542.
[8] Chefalo P, Pan Y, Nagy N, et al. Harding CV. Efficient metabolic engineering of GM3 on tumor cells by N-phenylacetyl-D-mannosamine [J]. J Biochem, 2006, 45 (11): 3733-3739.
[9] Yu S, Wang Q, Zhang J, et al. Synthesis and evaluation of protein conjugates of GM3 derivatives carrying modified sialic acids as highly immunogenic cancer vaccine candidates [J]. Medchemcomm, 2011, 2 (6): 524-530.
[10] Wang Q, Zhou Z, Tang S, et al. Carbohydrate-monophosphoryl lipid A conjugates are fully synthetic self-adjuvanting cancer vaccines eliciting robust immune responses in the mouse [J]. ACS Chem Biol, 2011, 7 (1): 235-240.
[11] Tang S, Wang Q, Guo Z. Synthesis of a monophosphoryl derivative of escherichia coli lipid A and its efficient coupling to a tumor-associated carbohydrate antigen [J]. Chemistry,2010, 16 (4): 1319-1325.
[12] Pan Y, Chefalo P, Nagy N, et al. Synthesis and immunological properties of N-modified GM3 antigens as therapeutic cancer vaccines [J]. J Med Chem, 2005, 48 (3): 875-883.
[13] Fujikawa K, Imamura A, Ishida H, et al. Synthesis of a GM3 ganglioside analogue carrying a phytoceramide moiety by intramolecular glycosylation as a key step [J]. Carbohydr Res, 2008, 343 (16): 2729-2734.
[14] Ando H, Koike Y, Ishida H, et al. Extending the possibility of an N-Troc-protected sialic acid donor toward variant sialo-glycoside synthesis [J]. Tetrahedron Lett, 2003, 44 (36): 6883-6.
[15] Ando H,Ishida H,Kiso M,et al.A synthetic approach to the c-series gangliosides containing sialyl-α (2→8) sialyl-α (2→8) sialic acid: Synthesis of ganglioside GT4,α (2→6) GT4 and GT3[J].Carbohydr Res,1997,300(3):207-217.
[16] Kameyama A, Ishida H, Kiso M, et al. Stereoselective synthesis of sialyl-lactotetraosylceramide and sialylneo-lactotetraosylceramide [J]. Carbohydr Res, 1990, 200: 269-285.
[17] Sun B, Jiang H. Total synthesis of dansyl and biotin functionalized ganglioside GM3 by chemoenzymatic method [J]. Sci China Chem, 2013, 56 (7): 933-938.
[18] Sun B, Jiang H. An efficient approach for total synthesis of aminopropyl functionalized ganglioside GM1b [J]. Tetrahedron Lett, 2012, 53 (42): 5711-5715.
[19] Sun B, Yang B, Huang X. Total synthesis of the aminopropyl functionalized ganglioside GM1 [J]. Sci China Chem, 2012, 55 (1): 31-35.